UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

31 Mar 2006

UCB - 2005 Annual Report on-line

Read More
31 Mar 2006

UCB - 2005 Annual Report on-line

Read More
14 Mar 2006

UCB - live analyst presentation

Read More
14 Mar 2006

UCB Full-Year 2005 Financial Results

Read More
2 Mar 2006

UCB Submits Biologics License Application to FDA for New Treatment in Crohn's Disease

Read More
23 Feb 2006

UCB Licenses Sepracor U.S. patents for antihistamine Levocetirizine

Read More

Stay up-to-date on the latest news and information from UCB